AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 177 filers reported holding AXSOME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,704 | +94.5% | 2,700 | +100.0% | 0.01% | -16.7% |
| Q2 2023 | $97,011 | +16.5% | 1,350 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $83,268 | -20.0% | 1,350 | 0.0% | 0.01% | -25.0% |
| Q4 2022 | $104,126 | +73.5% | 1,350 | 0.0% | 0.01% | +33.3% |
| Q3 2022 | $60,000 | +15.4% | 1,350 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $52,000 | -7.1% | 1,350 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $56,000 | +40.0% | 1,350 | +28.6% | 0.00% | +33.3% |
| Q4 2021 | $40,000 | +14.3% | 1,050 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $35,000 | -50.7% | 1,050 | 0.0% | 0.00% | -40.0% |
| Q2 2021 | $71,000 | +20.3% | 1,050 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $59,000 | -27.2% | 1,050 | +5.0% | 0.01% | -28.6% |
| Q4 2020 | $81,000 | +14.1% | 1,000 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $71,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |